Clinical Efficacy of Chelation Therapy in Patients with Low-Risk Myelodysplastic Syndrome

Clinical Efficacy of Chelation Therapy in Patients with Low-Risk Myelodysplastic Syndrome

The present literature review provides evidence that in patients with low-risk myelodysplastic syndrome and transfusion dependence blood parameters and survival rates can be improved by administration of iron chelators. Dose adequacy and therapy duration underlie clinical efficacy of chelators. Toxi...

Full description

Bibliographic Details
Main Authors: SV Gritsaev, II Kostroma, AA Zhernyakova
Format: Article
Language:Russian
Published: Practical Medicine Publishing House 2019-03-01
Series:Kliničeskaâ onkogematologiâ
Subjects:
myelodysplastic syndrome
low risk
transfusion dependence
iron chelators
survival
Online Access: http://bloodjournal.ru/wp-content/uploads/2019/03/2-6.pdf

Similar Items

Similar Items